{"gene":"CTSH","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2014,"finding":"CTSH (cathepsin H) overexpression protects insulin-secreting β-cells against cytokine-induced apoptosis by decreasing JNK and p38 signaling and reducing expression of proapoptotic factors Bim, DP5, and c-Myc. Additionally, CTSH overexpression upregulates Ins2 expression and increases insulin secretion, while Ctsh−/− mouse islets contain less insulin than wild-type islets.","method":"Overexpression in insulin-secreting cells with cytokine challenge, Ctsh knockout mouse islet analysis, measurement of apoptotic signaling intermediates (JNK, p38, Bim, DP5, c-Myc), Ins2 expression assay, insulin secretion assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (OE, KO, signaling pathway readouts, functional secretion assay) in a single study with strong mechanistic follow-up","pmids":["24982147"],"is_preprint":false},{"year":2021,"finding":"Proinflammatory cytokines (IL-1β + TNF-α + IFN-γ) downregulate CTSH transcription in human islets via DNA hypermethylation of three CpG residues in an open chromatin region in CTSH intron 1, driven by lowered Tet1/3 demethylase activities. A luciferase reporter assay confirmed that methylation of these CpGs reduces promoter activity.","method":"Luciferase reporter assay (methylated vs. unmethylated intron 1 CpG sites in HEK293 cells), bisulfite sequencing of human islets treated with cytokines, Tet1/3 activity measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay plus bisulfite sequencing in human islets; single lab but two orthogonal methods","pmids":["33992646"],"is_preprint":false},{"year":2023,"finding":"CTSH knockout in human microglia significantly increased phagocytosis of Aβ peptides, implicating CTSH as a negative regulator of microglial Aβ clearance. The functional variant rs2289702 (protective T allele) is associated with decreased CTSH expression via disruption of transcription factor binding.","method":"CTSH knockout in human microglia with Aβ phagocytosis assay; transcription factor binding affinity assay for rs2289702","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined cellular phenotype (phagocytosis) and TF binding assay; single lab","pmids":["36739351"],"is_preprint":false},{"year":2025,"finding":"IGF2BP2 binds CTSH mRNA in an m6A-dependent manner and enhances its stability, thereby promoting thyroid cancer cell proliferation, migration, invasion, and EMT. Overexpression of CTSH rescued the anti-tumorigenic effects of IGF2BP2 knockdown.","method":"RIP-qPCR and RNA pull-down assays confirming IGF2BP2–CTSH mRNA interaction; CCK8, EdU, Transwell assays; xenograft tumor model; IGF2BP2 knockdown with CTSH rescue","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA binding confirmed by RIP and pulldown, in vitro and in vivo phenotypic rescue; single lab","pmids":["41100504"],"is_preprint":false}],"current_model":"CTSH (cathepsin H) is a lysosomal cysteine protease that supports pancreatic β-cell survival and insulin secretion by suppressing JNK/p38-mediated apoptotic signaling (Bim, DP5, c-Myc); its transcription is negatively regulated by proinflammatory cytokines through Tet1/3-dependent DNA methylation of intronic CpG sites; in microglia, CTSH limits Aβ phagocytosis; and its mRNA stability is post-transcriptionally enhanced by the m6A reader IGF2BP2, promoting cancer cell invasiveness."},"narrative":{"teleology":[{"year":2014,"claim":"Before this work it was unknown whether CTSH had functions beyond general lysosomal proteolysis; overexpression and knockout experiments revealed that CTSH suppresses JNK/p38-mediated apoptosis in β-cells and is required for normal insulin content and secretion, establishing a direct cytoprotective and secretory role in pancreatic islets.","evidence":"Overexpression in insulin-secreting cells with cytokine challenge, Ctsh−/− mouse islet analysis, signaling pathway readouts, insulin secretion assays","pmids":["24982147"],"confidence":"High","gaps":["The direct proteolytic substrate(s) through which CTSH modulates JNK/p38 signaling remain unidentified","Whether CTSH acts catalytically or via a non-enzymatic mechanism in β-cell protection is unresolved","Relevance to human type 1 or type 2 diabetes in vivo has not been demonstrated"]},{"year":2021,"claim":"How cytokines silence CTSH was unclear; bisulfite sequencing and reporter assays showed that IL-1β/TNF-α/IFN-γ drive DNA hypermethylation of three intronic CpG sites via reduced Tet1/3 demethylase activity, providing an epigenetic mechanism for cytokine-mediated CTSH downregulation in human islets.","evidence":"Luciferase reporter assay with methylated vs. unmethylated CpG constructs in HEK293 cells; bisulfite sequencing of cytokine-treated human islets; Tet1/3 activity measurement","pmids":["33992646"],"confidence":"Medium","gaps":["Reporter assays were performed in HEK293 cells rather than β-cells, limiting direct cellular relevance","Whether pharmacological demethylation can restore CTSH expression and rescue β-cell function has not been tested","The upstream signals linking cytokine receptors to Tet1/3 suppression are not defined"]},{"year":2023,"claim":"CTSH had no established role in neuroinflammation; knockout in human microglia demonstrated that CTSH limits Aβ phagocytosis, and a protective genetic variant (rs2289702-T) reduces CTSH expression by disrupting transcription factor binding, connecting CTSH to microglial Aβ clearance.","evidence":"CTSH knockout in human microglia with Aβ phagocytosis assay; transcription factor binding affinity assay for rs2289702","pmids":["36739351"],"confidence":"Medium","gaps":["The mechanism by which CTSH suppresses phagocytic uptake (e.g., receptor processing, signaling modulation) is unknown","In vivo relevance to Alzheimer's disease pathology has not been tested","The transcription factor whose binding is disrupted by rs2289702 is not definitively identified"]},{"year":2025,"claim":"Post-transcriptional regulation of CTSH was unexplored; RIP and RNA pull-down experiments showed that the m6A reader IGF2BP2 binds and stabilizes CTSH mRNA, and CTSH overexpression rescued the anti-tumorigenic effects of IGF2BP2 knockdown, placing CTSH as a key downstream effector of epitranscriptomic signaling in cancer.","evidence":"RIP-qPCR, RNA pull-down, CCK8/EdU/Transwell assays, xenograft model, IGF2BP2 knockdown with CTSH rescue in thyroid cancer cells","pmids":["41100504"],"confidence":"Medium","gaps":["The specific m6A site(s) on CTSH mRNA that mediate IGF2BP2 binding have not been mapped","Whether the pro-tumorigenic activity requires CTSH catalytic function is untested","Generalizability beyond thyroid cancer is unknown"]},{"year":null,"claim":"The direct proteolytic substrates of CTSH responsible for its signaling effects in β-cells, microglia, and cancer cells remain unidentified, and no structural or biochemical basis connects CTSH catalytic activity to modulation of JNK/p38, phagocytosis, or EMT.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No substrate has been identified that mechanistically links CTSH proteolysis to JNK/p38 suppression or phagocytic regulation","Catalytic-dead mutant experiments have not been performed in any of the reported contexts","No structural model explains CTSH's aminopeptidase specificity in these biological settings"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3]}],"complexes":[],"partners":["IGF2BP2"],"other_free_text":[]},"mechanistic_narrative":"CTSH (cathepsin H) is a lysosomal cysteine protease that protects pancreatic β-cells from cytokine-induced apoptosis by suppressing JNK and p38 MAPK signaling and reducing expression of the proapoptotic effectors Bim, DP5, and c-Myc, while simultaneously promoting Ins2 transcription and insulin secretion [PMID:24982147]. Proinflammatory cytokines downregulate CTSH transcription in human islets through Tet1/3-dependent DNA hypermethylation of CpG sites in an intronic regulatory element [PMID:33992646]. In human microglia, CTSH acts as a negative regulator of amyloid-β phagocytosis, linking a protective genetic variant (rs2289702) that reduces CTSH expression to enhanced Aβ clearance [PMID:36739351]. CTSH mRNA stability is post-transcriptionally enhanced by the m6A reader IGF2BP2, and elevated CTSH levels promote cancer cell proliferation, migration, and epithelial–mesenchymal transition [PMID:41100504]."},"prefetch_data":{"uniprot":{"accession":"P09668","full_name":"Pro-cathepsin H","aliases":[],"length_aa":335,"mass_kda":37.4,"function":"Important for the overall degradation of proteins in lysosomes","subcellular_location":"Lysosome","url":"https://www.uniprot.org/uniprotkb/P09668/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CTSH","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CTSH","total_profiled":1310},"omim":[{"mim_id":"615431","title":"MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23","url":"https://www.omim.org/entry/615431"},{"mim_id":"602620","title":"LEGUMAIN; LGMN","url":"https://www.omim.org/entry/602620"},{"mim_id":"222100","title":"TYPE 1 DIABETES MELLITUS; T1D","url":"https://www.omim.org/entry/222100"},{"mim_id":"116820","title":"CATHEPSIN H; CTSH","url":"https://www.omim.org/entry/116820"},{"mim_id":"116810","title":"CATHEPSIN B; CTSB","url":"https://www.omim.org/entry/116810"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Cytoplasmic bodies","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lung","ntpm":329.6}],"url":"https://www.proteinatlas.org/search/CTSH"},"hgnc":{"alias_symbol":["ACC-4","ACC-5","ACC4","ACC5"],"prev_symbol":["CPSB"]},"alphafold":{"accession":"P09668","domains":[{"cath_id":"3.90.70.10","chopping":"89-334","consensus_level":"high","plddt":97.1213,"start":89,"end":334},{"cath_id":"1.10.20","chopping":"31-73","consensus_level":"high","plddt":97.6342,"start":31,"end":73}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P09668","model_url":"https://alphafold.ebi.ac.uk/files/AF-P09668-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P09668-F1-predicted_aligned_error_v6.png","plddt_mean":93.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CTSH","jax_strain_url":"https://www.jax.org/strain/search?query=CTSH"},"sequence":{"accession":"P09668","fasta_url":"https://rest.uniprot.org/uniprotkb/P09668.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P09668/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P09668"}},"corpus_meta":[{"pmid":"15122528","id":"PMC_15122528","title":"The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae.","date":"2004","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15122528","citation_count":105,"is_preprint":false},{"pmid":"24982147","id":"PMC_24982147","title":"CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24982147","citation_count":97,"is_preprint":false},{"pmid":"11751838","id":"PMC_11751838","title":"Streptococcus pneumoniae capsule biosynthesis protein CpsB is a novel manganese-dependent phosphotyrosine-protein phosphatase.","date":"2002","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/11751838","citation_count":96,"is_preprint":false},{"pmid":"25525168","id":"PMC_25525168","title":"Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 families with early-onset high myopia by exome sequencing.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25525168","citation_count":93,"is_preprint":false},{"pmid":"11606571","id":"PMC_11606571","title":"CpsB is a modulator of capsule-associated tyrosine kinase activity in Streptococcus pneumoniae.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11606571","citation_count":75,"is_preprint":false},{"pmid":"19616007","id":"PMC_19616007","title":"Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19616007","citation_count":52,"is_preprint":false},{"pmid":"24659769","id":"PMC_24659769","title":"Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability.","date":"2014","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/24659769","citation_count":34,"is_preprint":false},{"pmid":"14614062","id":"PMC_14614062","title":"Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes.","date":"2003","source":"Journal of medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/14614062","citation_count":30,"is_preprint":false},{"pmid":"10747101","id":"PMC_10747101","title":"Evaluation of serotype prediction by cpsA-cpsB gene polymorphism in Streptococcus pneumoniae.","date":"2000","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10747101","citation_count":24,"is_preprint":false},{"pmid":"33992646","id":"PMC_33992646","title":"Genetic and environmental factors regulate the type 1 diabetes gene CTSH via differential DNA methylation.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33992646","citation_count":21,"is_preprint":false},{"pmid":"21605684","id":"PMC_21605684","title":"Crystal structures of YwqE from Bacillus subtilis and CpsB from Streptococcus pneumoniae, unique metal-dependent tyrosine phosphatases.","date":"2011","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/21605684","citation_count":19,"is_preprint":false},{"pmid":"36739351","id":"PMC_36739351","title":"Functional genomics identify causal variant underlying the protective CTSH locus for Alzheimer's disease.","date":"2023","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36739351","citation_count":16,"is_preprint":false},{"pmid":"38050341","id":"PMC_38050341","title":"Integrating multi-omics data to analyze the potential pathogenic mechanism of CTSH gene involved in type 1 diabetes in the exocrine pancreas.","date":"2024","source":"Briefings in functional genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38050341","citation_count":15,"is_preprint":false},{"pmid":"14715761","id":"PMC_14715761","title":"Serotype 14 variants of the France 9V(-3) clone from Baltimore, Maryland, can be differentiated by the cpsB gene.","date":"2004","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/14715761","citation_count":12,"is_preprint":false},{"pmid":"23194664","id":"PMC_23194664","title":"Dual inhibition of DNA polymerase PolC and protein tyrosine phosphatase CpsB uncovers a novel antibiotic target.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23194664","citation_count":12,"is_preprint":false},{"pmid":"37471639","id":"PMC_37471639","title":"Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.","date":"2023","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37471639","citation_count":9,"is_preprint":false},{"pmid":"26245339","id":"PMC_26245339","title":"Polymorphisms in the CTSH gene may influence the progression of diabetic retinopathy: a candidate-gene study in the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).","date":"2015","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/26245339","citation_count":8,"is_preprint":false},{"pmid":"39228680","id":"PMC_39228680","title":"Identifying and Validating Extracellular Matrix-Related Gene CTSH in Diabetic Foot Ulcer Using Bioinformatics and Machine Learning.","date":"2024","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/39228680","citation_count":5,"is_preprint":false},{"pmid":"28573276","id":"PMC_28573276","title":"Reaction mechanism of the metallohydrolase CpsB from Streptococcus pneumoniae, a promising target for novel antimicrobial agents.","date":"2017","source":"Dalton transactions (Cambridge, England : 2003)","url":"https://pubmed.ncbi.nlm.nih.gov/28573276","citation_count":5,"is_preprint":false},{"pmid":"34924338","id":"PMC_34924338","title":"Rapid identification of Streptococcus pneumoniae serotypes by cpsB gene-based sequetyping combined with multiplex PCR.","date":"2021","source":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/34924338","citation_count":4,"is_preprint":false},{"pmid":"41138838","id":"PMC_41138838","title":"From plasma proteomics Mendelian randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease.","date":"2025","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41138838","citation_count":0,"is_preprint":false},{"pmid":"41100504","id":"PMC_41100504","title":"IGF2BP2 contributes to thyroid cancer progression by enhancing the stability of m6A-modified CTSH mRNA.","date":"2025","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41100504","citation_count":0,"is_preprint":false},{"pmid":"12545211","id":"PMC_12545211","title":"RFLP analysis of 1-aminocyclopropane-1-carboxylate synthase ACC2 and ACC4 genes from Polish cultivars of tomato.","date":"2002","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/12545211","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.17.25326042","title":"Integrative multi-omics QTL colocalization maps regulatory architecture in aging human brain","date":"2025-04-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.17.25326042","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14262,"output_tokens":1215,"usd":0.030506},"stage2":{"model":"claude-opus-4-6","input_tokens":4456,"output_tokens":3493,"usd":0.164408},"total_usd":0.194914,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"CTSH (cathepsin H) overexpression protects insulin-secreting β-cells against cytokine-induced apoptosis by decreasing JNK and p38 signaling and reducing expression of proapoptotic factors Bim, DP5, and c-Myc. Additionally, CTSH overexpression upregulates Ins2 expression and increases insulin secretion, while Ctsh−/− mouse islets contain less insulin than wild-type islets.\",\n      \"method\": \"Overexpression in insulin-secreting cells with cytokine challenge, Ctsh knockout mouse islet analysis, measurement of apoptotic signaling intermediates (JNK, p38, Bim, DP5, c-Myc), Ins2 expression assay, insulin secretion assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (OE, KO, signaling pathway readouts, functional secretion assay) in a single study with strong mechanistic follow-up\",\n      \"pmids\": [\"24982147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Proinflammatory cytokines (IL-1β + TNF-α + IFN-γ) downregulate CTSH transcription in human islets via DNA hypermethylation of three CpG residues in an open chromatin region in CTSH intron 1, driven by lowered Tet1/3 demethylase activities. A luciferase reporter assay confirmed that methylation of these CpGs reduces promoter activity.\",\n      \"method\": \"Luciferase reporter assay (methylated vs. unmethylated intron 1 CpG sites in HEK293 cells), bisulfite sequencing of human islets treated with cytokines, Tet1/3 activity measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay plus bisulfite sequencing in human islets; single lab but two orthogonal methods\",\n      \"pmids\": [\"33992646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CTSH knockout in human microglia significantly increased phagocytosis of Aβ peptides, implicating CTSH as a negative regulator of microglial Aβ clearance. The functional variant rs2289702 (protective T allele) is associated with decreased CTSH expression via disruption of transcription factor binding.\",\n      \"method\": \"CTSH knockout in human microglia with Aβ phagocytosis assay; transcription factor binding affinity assay for rs2289702\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype (phagocytosis) and TF binding assay; single lab\",\n      \"pmids\": [\"36739351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IGF2BP2 binds CTSH mRNA in an m6A-dependent manner and enhances its stability, thereby promoting thyroid cancer cell proliferation, migration, invasion, and EMT. Overexpression of CTSH rescued the anti-tumorigenic effects of IGF2BP2 knockdown.\",\n      \"method\": \"RIP-qPCR and RNA pull-down assays confirming IGF2BP2–CTSH mRNA interaction; CCK8, EdU, Transwell assays; xenograft tumor model; IGF2BP2 knockdown with CTSH rescue\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding confirmed by RIP and pulldown, in vitro and in vivo phenotypic rescue; single lab\",\n      \"pmids\": [\"41100504\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CTSH (cathepsin H) is a lysosomal cysteine protease that supports pancreatic β-cell survival and insulin secretion by suppressing JNK/p38-mediated apoptotic signaling (Bim, DP5, c-Myc); its transcription is negatively regulated by proinflammatory cytokines through Tet1/3-dependent DNA methylation of intronic CpG sites; in microglia, CTSH limits Aβ phagocytosis; and its mRNA stability is post-transcriptionally enhanced by the m6A reader IGF2BP2, promoting cancer cell invasiveness.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CTSH (cathepsin H) is a lysosomal cysteine protease that protects pancreatic β-cells from cytokine-induced apoptosis by suppressing JNK and p38 MAPK signaling and reducing expression of the proapoptotic effectors Bim, DP5, and c-Myc, while simultaneously promoting Ins2 transcription and insulin secretion [PMID:24982147]. Proinflammatory cytokines downregulate CTSH transcription in human islets through Tet1/3-dependent DNA hypermethylation of CpG sites in an intronic regulatory element [PMID:33992646]. In human microglia, CTSH acts as a negative regulator of amyloid-β phagocytosis, linking a protective genetic variant (rs2289702) that reduces CTSH expression to enhanced Aβ clearance [PMID:36739351]. CTSH mRNA stability is post-transcriptionally enhanced by the m6A reader IGF2BP2, and elevated CTSH levels promote cancer cell proliferation, migration, and epithelial–mesenchymal transition [PMID:41100504].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Before this work it was unknown whether CTSH had functions beyond general lysosomal proteolysis; overexpression and knockout experiments revealed that CTSH suppresses JNK/p38-mediated apoptosis in β-cells and is required for normal insulin content and secretion, establishing a direct cytoprotective and secretory role in pancreatic islets.\",\n      \"evidence\": \"Overexpression in insulin-secreting cells with cytokine challenge, Ctsh−/− mouse islet analysis, signaling pathway readouts, insulin secretion assays\",\n      \"pmids\": [\"24982147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The direct proteolytic substrate(s) through which CTSH modulates JNK/p38 signaling remain unidentified\",\n        \"Whether CTSH acts catalytically or via a non-enzymatic mechanism in β-cell protection is unresolved\",\n        \"Relevance to human type 1 or type 2 diabetes in vivo has not been demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"How cytokines silence CTSH was unclear; bisulfite sequencing and reporter assays showed that IL-1β/TNF-α/IFN-γ drive DNA hypermethylation of three intronic CpG sites via reduced Tet1/3 demethylase activity, providing an epigenetic mechanism for cytokine-mediated CTSH downregulation in human islets.\",\n      \"evidence\": \"Luciferase reporter assay with methylated vs. unmethylated CpG constructs in HEK293 cells; bisulfite sequencing of cytokine-treated human islets; Tet1/3 activity measurement\",\n      \"pmids\": [\"33992646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Reporter assays were performed in HEK293 cells rather than β-cells, limiting direct cellular relevance\",\n        \"Whether pharmacological demethylation can restore CTSH expression and rescue β-cell function has not been tested\",\n        \"The upstream signals linking cytokine receptors to Tet1/3 suppression are not defined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CTSH had no established role in neuroinflammation; knockout in human microglia demonstrated that CTSH limits Aβ phagocytosis, and a protective genetic variant (rs2289702-T) reduces CTSH expression by disrupting transcription factor binding, connecting CTSH to microglial Aβ clearance.\",\n      \"evidence\": \"CTSH knockout in human microglia with Aβ phagocytosis assay; transcription factor binding affinity assay for rs2289702\",\n      \"pmids\": [\"36739351\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The mechanism by which CTSH suppresses phagocytic uptake (e.g., receptor processing, signaling modulation) is unknown\",\n        \"In vivo relevance to Alzheimer's disease pathology has not been tested\",\n        \"The transcription factor whose binding is disrupted by rs2289702 is not definitively identified\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Post-transcriptional regulation of CTSH was unexplored; RIP and RNA pull-down experiments showed that the m6A reader IGF2BP2 binds and stabilizes CTSH mRNA, and CTSH overexpression rescued the anti-tumorigenic effects of IGF2BP2 knockdown, placing CTSH as a key downstream effector of epitranscriptomic signaling in cancer.\",\n      \"evidence\": \"RIP-qPCR, RNA pull-down, CCK8/EdU/Transwell assays, xenograft model, IGF2BP2 knockdown with CTSH rescue in thyroid cancer cells\",\n      \"pmids\": [\"41100504\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The specific m6A site(s) on CTSH mRNA that mediate IGF2BP2 binding have not been mapped\",\n        \"Whether the pro-tumorigenic activity requires CTSH catalytic function is untested\",\n        \"Generalizability beyond thyroid cancer is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct proteolytic substrates of CTSH responsible for its signaling effects in β-cells, microglia, and cancer cells remain unidentified, and no structural or biochemical basis connects CTSH catalytic activity to modulation of JNK/p38, phagocytosis, or EMT.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No substrate has been identified that mechanistically links CTSH proteolysis to JNK/p38 suppression or phagocytic regulation\",\n        \"Catalytic-dead mutant experiments have not been performed in any of the reported contexts\",\n        \"No structural model explains CTSH's aminopeptidase specificity in these biological settings\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005357801\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"IGF2BP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway term. Let me correct it:\n\n```json\n{\n  \"mechanistic_narrative\": \"CTSH (cathepsin H) is a lysosomal cysteine protease that protects pancreatic β-cells from cytokine-induced apoptosis by suppressing JNK and p38 MAPK signaling and reducing expression of the proapoptotic effectors Bim, DP5, and c-Myc, while simultaneously promoting Ins2 transcription and insulin secretion [PMID:24982147]. Proinflammatory cytokines downregulate CTSH transcription in human islets through Tet1/3-dependent DNA hypermethylation of CpG sites in an intronic regulatory element [PMID:33992646]. In human microglia, CTSH acts as a negative regulator of amyloid-β phagocytosis, linking a protective genetic variant (rs2289702) that reduces CTSH expression to enhanced Aβ clearance [PMID:36739351]. CTSH mRNA stability is post-transcriptionally enhanced by the m6A reader IGF2BP2, and elevated CTSH levels promote cancer cell proliferation, migration, and epithelial–mesenchymal transition [PMID:41100504].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Before this work it was unknown whether CTSH had functions beyond general lysosomal proteolysis; overexpression and knockout experiments revealed that CTSH suppresses JNK/p38-mediated apoptosis in β-cells and is required for normal insulin content and secretion, establishing a direct cytoprotective and secretory role in pancreatic islets.\",\n      \"evidence\": \"Overexpression in insulin-secreting cells with cytokine challenge, Ctsh−/− mouse islet analysis, signaling pathway readouts, insulin secretion assays\",\n      \"pmids\": [\"24982147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The direct proteolytic substrate(s) through which CTSH modulates JNK/p38 signaling remain unidentified\",\n        \"Whether CTSH acts catalytically or via a non-enzymatic mechanism in β-cell protection is unresolved\",\n        \"Relevance to human type 1 or type 2 diabetes in vivo has not been demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"How cytokines silence CTSH was unclear; bisulfite sequencing and reporter assays showed that IL-1β/TNF-α/IFN-γ drive DNA hypermethylation of three intronic CpG sites via reduced Tet1/3 demethylase activity, providing an epigenetic mechanism for cytokine-mediated CTSH downregulation in human islets.\",\n      \"evidence\": \"Luciferase reporter assay with methylated vs. unmethylated CpG constructs in HEK293 cells; bisulfite sequencing of cytokine-treated human islets; Tet1/3 activity measurement\",\n      \"pmids\": [\"33992646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Reporter assays were performed in HEK293 cells rather than β-cells, limiting direct cellular relevance\",\n        \"Whether pharmacological demethylation can restore CTSH expression and rescue β-cell function has not been tested\",\n        \"The upstream signals linking cytokine receptors to Tet1/3 suppression are not defined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CTSH had no established role in neuroinflammation; knockout in human microglia demonstrated that CTSH limits Aβ phagocytosis, and a protective genetic variant (rs2289702-T) reduces CTSH expression by disrupting transcription factor binding, connecting CTSH to microglial Aβ clearance.\",\n      \"evidence\": \"CTSH knockout in human microglia with Aβ phagocytosis assay; transcription factor binding affinity assay for rs2289702\",\n      \"pmids\": [\"36739351\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The mechanism by which CTSH suppresses phagocytic uptake is unknown\",\n        \"In vivo relevance to Alzheimer's disease pathology has not been tested\",\n        \"The transcription factor whose binding is disrupted by rs2289702 is not definitively identified\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Post-transcriptional regulation of CTSH was unexplored; RIP and RNA pull-down experiments showed that the m6A reader IGF2BP2 binds and stabilizes CTSH mRNA, and CTSH overexpression rescued the anti-tumorigenic effects of IGF2BP2 knockdown, placing CTSH as a key downstream effector of epitranscriptomic signaling in cancer.\",\n      \"evidence\": \"RIP-qPCR, RNA pull-down, CCK8/EdU/Transwell assays, xenograft model, IGF2BP2 knockdown with CTSH rescue in thyroid cancer cells\",\n      \"pmids\": [\"41100504\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The specific m6A site(s) on CTSH mRNA that mediate IGF2BP2 binding have not been mapped\",\n        \"Whether the pro-tumorigenic activity requires CTSH catalytic function is untested\",\n        \"Generalizability beyond thyroid cancer is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct proteolytic substrates of CTSH responsible for its signaling effects in β-cells, microglia, and cancer cells remain unidentified, and no structural or biochemical basis connects CTSH catalytic activity to modulation of JNK/p38, phagocytosis, or EMT.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No substrate has been identified that mechanistically links CTSH proteolysis to JNK/p38 suppression or phagocytic regulation\",\n        \"Catalytic-dead mutant experiments have not been performed in any of the reported contexts\",\n        \"No structural model explains CTSH's aminopeptidase specificity in these biological settings\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"IGF2BP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}